Dr Benjamin Mullish

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

NIHR Clinical Lecturer

Contact

Location

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

Summary

Benjamin Mullish is a NIHR Academic Clinical Lecturer in the Department of Metabolism, Digestion and Reproduction at Imperial College London and a Post-CCT fellow in Gastroenterology and Hepatology at St Mary's Hospital, Imperial College Healthcare NHS Trust. He completed his PhD at Imperial College London (funded by a MRC Clinical Research Training Fellowship), and was previously an Imperial NIHR-funded Academic Clinical Fellow.

Selected Publications

Journal Articles

Yip AYG, King OG, Omelchenko O, et al.Yip AYG, King OG, Omelchenko O, Kurkimat S, Horrocks V, Mostyn P, Danckert N, Ghani R, Satta G, Jauneikaite E, Davies FJ, Clarke TB, Mullish BH, Marchesi JR, McDonald JAK close, 2023, Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites, Nature Communications, Vol:14

Routy B, Lenehan JG, Miller WH, et al.Routy B, Lenehan JG, Miller WH, Jamal R, Messaoudene M, Daisley BA, Hes C, Al KF, Martinez-Gili L, Punčochář M, Ernst S, Logan D, Belanger K, Esfahani K, Richard C, Ninkov M, Piccinno G, Armanini F, Pinto F, Krishnamoorthy M, Figueredo R, Thebault P, Takis P, Magrill J, Ramsay L, Derosa L, Marchesi JR, Parvathy SN, Elkrief A, Watson IR, Lapointe R, Segata N, Mansour Haeryfar SM, Mullish BH, Silverman MS, Burton JP, Maleki Vareki S close, 2023, Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial, Nature Medicine, Vol:29, ISSN:1078-8956, Pages:2121-2132

Ghani R, Mullish BH, McDonald JAK, et al.Ghani R, Mullish BH, McDonald JAK, Ghazy A, Williams HRT, Brannigan ET, Mookerjee S, Satta G, Gilchrist M, Duncan N, Corbett R, Innes AJ, Pavlů J, Thursz MR, Davies F, Marchesi JR close, 2021, Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms, Clinical Infectious Diseases, Vol:72, ISSN:1058-4838, Pages:1444-1447

Mullish BH, Michael DR, McDonald JA, et al.Mullish BH, Michael DR, McDonald JA, Masetti G, Plummer SF, Marchesi JR close, 2021, Identifying the factors influencing outcome in probiotic studies in overweight and obese patients: host or microbiome?, Gut, Vol:70, Pages:225-226

Allegretti JR, Kelly CR, Grinspan A, et al.Allegretti JR, Kelly CR, Grinspan A, Mullish BH, Kassam Z, Fischer M close, 2020, Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection, Gastroenterology, Vol:159, ISSN:0016-5085, Pages:1982-1984

Ianiro G, Mullish BH, Kelly CR, et al.Ianiro G, Mullish BH, Kelly CR, Kassam Z, Kuijper EJ, Ng SC, Iqbal TH, Allegretti JR, Bibbò S, Sokol H, Zhang F, Fischer M, Costello SP, Keller JJ, Masucci L, van Prehn J, Quaranta G, Quraishi MN, Segal J, Kao D, Satokari R, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota G close, 2020, Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic, Gut, Vol:69, ISSN:0017-5749, Pages:1555-1563

Mullish BH, McDonald JAK, Pechlivanis A, et al.Mullish BH, McDonald JAK, Pechlivanis A, Allegretti JR, Kao D, Barker GF, Kapila D, Petrof EO, Joyce SA, Gahan CGM, Glegola-Madejska I, Williams HRT, Holmes E, Clarke TB, Thursz MR, Marchesi JR close, 2019, Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent <i>Clostridioides difficile</i> infection, Gut, Vol:68, ISSN:0017-5749, Pages:1791-1800

Allegretti JR, Mullish BH, Kelly C, et al.Allegretti JR, Mullish BH, Kelly C, Fischer M close, 2019, The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications., Lancet, Vol:394, Pages:420-431

McDonald JAK, Mullish BH, Pechlivanis A, et al.McDonald JAK, Mullish BH, Pechlivanis A, Liu Z, Brignardello J, Kao D, Holmes E, Li JV, Clarke TB, Thursz MR, Marchesi JR close, 2018, Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota., Gastroenterology, Vol:155, Pages:1495-1507.e15

Mullish BH, Quraishi MN, Segal JP, et al.Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT close, 2018, The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines., Gut, Vol:67, Pages:1920-1941

Dhar A, Mullish BH, Thursz MR, 2017, Grand round: anticoagulation in chronic liver disease, Journal of Hepatology, Vol:66, ISSN:1600-0641, Pages:1313-1326

Mullish BH, Marchesi JR, Thursz MR, et al.Mullish BH, Marchesi JR, Thursz MR, Williams HRT close, 2015, Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection., Qjm, Vol:108, Pages:355-359

Mullish BH, 2014, Case 25-2014: A man with ulcerative colitis and bloody diarrhea., New England Journal of Medicine, Vol:371, ISSN:0028-4793

Mullish BH, Kabir MS, Thursz MR, et al.Mullish BH, Kabir MS, Thursz MR, Dhar A close, 2014, Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation, Alimentary Pharmacology & Therapeutics, Vol:40, ISSN:0269-2813, Pages:880-892

More Publications